Detalles de la búsqueda
1.
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.
Front Immunol
; 15: 1293931, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38469299
2.
Breast cancer detection by analyzing the volatile organic compound (VOC) signature in human urine.
Sci Rep
; 12(1): 14873, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36050339
3.
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.
Clin Cancer Res
; 28(17): 3658-3668, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35727601
4.
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.
J Immunother Cancer
; 9(6)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34158317
5.
Prevention of irinotecan associated diarrhea by intestinal alkalization. A pilot study in gastrointestinal cancer patients.
Clin Transl Oncol
; 8(3): 208-12, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16648121
6.
Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
Leuk Lymphoma
; 55(1): 51-5, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23573825
7.
Prevention of irinotecan associated diarrhea by intestinal alkalization. A pilot study in gastrointestinal cancer patients
Clin. transl. oncol. (Print)
; 8(3): 208-212, mar. 2006. tab
Artículo
en En
| IBECS (España) | ID: ibc-047656
Resultados
1 -
7
de 7
1
Próxima >
>>